Hydrolyzed collagen improves bone metabolism and biomechanical parameters in ovariectomized mice: An in vitro and in vivo study

Bone

Volumn 46, Issue 3, 2010, Pages 827-834

  Guillerminet, Fanny ^a,c   Beaupied, Hélène ^b   Fabien Soulé, Véronique ^c   Tomé, Daniel ^a   Benhamou, Claude Laurent ^b   Roux, Christian ^d   Blais, Anne ^a  

^a INRA Institut National de la Recherche Agronomique   (France)

^b UNIVERSITÉ D'ORLÉANS   (France)

^c Rousselot SAS   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Bone mineral density; Hydrolyzed collagen; Microarchitecture; Osteoblast; Osteoclast

Indexed keywords

ALKALINE PHOSPHATASE; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN; COLLAGEN TYPE 1; PROTEIN INTAKE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE DENSITY; BONE METABOLISM; BONE REMODELING; BONE STRENGTH; BONE STRUCTURE; CELL ACTIVITY; CONTROLLED STUDY; CORTICAL BONE; ENZYME ACTIVITY; FEMALE; FEMUR; HYDROLYSIS; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OVARIECTOMY; ADMINISTRATION AND DOSAGE; ANIMAL; BAGG ALBINO MOUSE; BONE; BONE DEVELOPMENT; BOVINAE; C3H MOUSE; CELL CULTURE; CELL ENLARGEMENT; COCULTURE; COMPARATIVE STUDY; CYTOLOGY; DIET; DRUG EFFECTS; FISH; METABOLISM; PHYSIOLOGY; PROTEIN INTAKE; SWINE;

ANIMALS; BIOMECHANICS; BONE AND BONES; BONE DENSITY; CATTLE; CELL ENLARGEMENT; CELLS, CULTURED; COCULTURE TECHNIQUES; COLLAGEN TYPE I; DIET; DIETARY PROTEINS; FEMALE; FISHES; HYDROLYSIS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; OVARIECTOMY; SWINE; BIOMECHANICAL PHENOMENA;

EID: 77649182546     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.10.035     Document Type: Article

References (40)

1. Nomura Y., et al. Increase in bone mineral density through oral administration of shark gelatin to ovariectomized rats. Nutrition 2005, 21(11-12):1120-1126.
2. Takeuchi Y., Nakayama K., Matsumoto T. Differentiation and cell surface expression of transforming growth factor-beta receptors are regulated by interaction with matrix collagen in murine osteoblastic cells. J. Biol. Chem. 1996, 271(7):3938-3944.
3. Takeuchi Y., et al. Differentiation and transforming growth factor-beta receptor down-regulation by collagen-alpha2beta1 integrin interaction is mediated by focal adhesion kinase and its downstream signals in murine osteoblastic cells. J. Biol. Chem. 1997, 272(46):29309-29316.
4. Wu J., et al. Assessment of effectiveness of oral administration of collagen peptide on bone metabolism in growing and mature rats. J. Bone Miner. Metab. 2004, 22(6):547-553.
5. Koyama Y., et al. Ingestion of gelatin has differential effect on bone mineral density and body weight in protein undernutrition. J. Nutr. Sci. Vitaminol. (Tokyo) 2001, 47(1):84-86.
6. Adam M., et al. Postmenopausal osteoporosis. Treatment with calcitonin and a diet rich in collagen proteins. Cas. Lek. Cesk. 1996, 135(3):74-78.
7. Bonjour J.P. Dietary protein: an essential nutrient for bone health. J. Am. Coll. Nutr. 2005, 24(6 Suppl):526S-536S.
8. Thissen J.P., Ketelslegers J.M., Underwood L.E. Nutritional regulation of the insulin-like growth factors. Endocr. Rev. 1994, 15(1):80-101.
9. Schurch M.A., et al. Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 1998, 128(10):801-809.
10. Oesser S., et al. Oral administration of (14)C labeled gelatin hydrolysate leads to an accumulation of radioactivity in cartilage of mice (C57/BL). J. Nutr. 1999, 129(10):1891-1895.
11. Iwai K., et al. Identification of food-derived collagen peptides in human blood after oral ingestion of gelatin hydrolysates. J. Agric. Food Chem. 2005, 53(16):6531-6536.
12. Aito-Inoue M., et al. Transport of a tripeptide, Gly-Pro-Hyp, across the porcine intestinal brush-border membrane. J. Pept. Sci. 2007, 13(7):468-474.
13. Postlethwaite A.E., Seyer J.M., Kang A.H. Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides. Proc. Natl. Acad. Sci. U. S. A. 1978, 75(2):871-875.
14. Laskin D.L., et al. Chemotactic activity of collagen-like polypeptides for human peripheral blood neutrophils. J. Leukoc. Biol. 1986, 39(3):255-266.
15. Postlethwaite A.E., Kang A.H. Collagen-and collagen peptide-induced chemotaxis of human blood monocytes. J. Exp. Med. 1976, 143(6):1299-1307.
16. Mizuno M., Kuboki Y. Osteoblast-related gene expression of bone marrow cells during the osteoblastic differentiation induced by type I collagen. J. Biochem. 2001, 129(1):133-138.
17. Kim S.K., et al. Angiotensin I converting enzyme inhibitory peptides purified from bovine skin gelatin hydrolysate. J. Agric. Food Chem. 2001, 49(6):2992-2997.
18. Oshima G., Shimabukuro H., Nagasawa K. Peptide inhibitors of angiotensin I-converting enzyme in digests of gelatin by bacterial collagenase. Biochim. Biophys. Acta 1979, 566(1):128-137.
19. Knight C.G., et al. Collagen-platelet interaction: Gly-Pro-Hyp is uniquely specific for platelet Gp VI and mediates platelet activation by collagen. Cardiovasc. Res. 1999, 41(2):450-457.
20. Nagy T.R., Clair A.L. Precision and accuracy of dual-energy X-ray absorptiometry for determining in vivo body composition of mice. Obes. Res. 2000, 8(5):392-398.
21. Turner C.H., Burr D.B. Basic biomechanical measurements of bone: a tutorial. Bone 1993, 14(4):595-608.
22. Di Masso R.J., et al. Long-bone biomechanics in mice selected for body conformation. Bone 1997, 20(6):539-545.
23. Dimai H.P., et al. Alkaline phosphatase levels and osteoprogenitor cell numbers suggest bone formation may contribute to peak bone density differences between two inbred strains of mice. Bone 1998, 22(3):211-216.
24. Blais A., et al. Oral bovine lactoferrin improves bone status of ovariectomized mice. Am. J. Physiol. Endocrinol. Metab. 2009.
25. Beaupied H., Lespessailles E., Benhamou C.L. Evaluation of macrostructural bone biomechanics. Joint Bone Spine 2007, 74(3):233-239.
26. Currey J.D. Bone strength: what are we trying to measure?. Calcif. Tissue Int. 2001, 68(4):205-210.
27. Burr D.B. The contribution of the organic matrix to bone's material properties. Bone 2002, 31(1):8-11.
28. Mann V., et al. A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. J. Clin. Invest. 2001, 107(7):899-907.
29. Voide R., van Lenthe G.H., Muller R. Differential effects of bone structural and material properties on bone competence in C57BL/6 and C3H/He inbred strains of mice. Calcif. Tissue Int. 2008, 83(1):61-69.
30. Bouxsein M.L., et al. Ovariectomy-induced bone loss varies among inbred strains of mice. J. Bone Miner. Res. 2005, 20(7):1085-1092.
31. Li C.Y., et al. Genetic background influences cortical bone response to ovariectomy. J. Bone Miner. Res. 2005, 20(12):2150-2158.
32. Ward W.E., et al. Serum equol, bone mineral density and biomechanical bone strength differ among four mouse strains. J. Nutr. Biochem. 2005, 16(12):743-749.
33. Ohara H., Matsumoto H., Ito K., Iwai K., Sato K. Comparison of quantity and structures of hydroxyproline-containing peptides in human blood after oral ingestion of gelatin hydrolysates from different sources. J. Agric. Food Chem. 2007, 55(4):1532-1535.
34. Andrianarivo A.G., et al. Growth on type I collagen promotes expression of the osteoblastic phenotype in human osteosarcoma MG-63 cells. J. Cell. Physiol. 1992, 153(2):256-265.
35. Lynch M.P., et al. The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization. Exp. Cell. Res. 1995, 216(1):35-45.
36. Stein G.S., Lian J.B. Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr. Rev. 1993, 14(4):424-442.
37. Owen T.A., et al. Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures. Endocrinology 1991, 128(3):1496-1504.
38. Quarles L.D., et al. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. J. Bone Miner. Res. 1992, 7(6):683-692.
39. Oreffo R.O., et al. Activation of the bone-derived latent TGF beta complex by isolated osteoclasts. Biochem. Biophys. Res. Commun. 1989, 158(3):817-823.
40. Xiao G., et al. Role of the alpha2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor. J. Biol. Chem. 1998, 273(49):32988-32994.